Literature DB >> 26656213

Relationship between discriminative stimulus effects and plasma methamphetamine and amphetamine levels of intramuscular methamphetamine in male rhesus monkeys.

Matthew L Banks1, Douglas A Smith2, David F Kisor3, Justin L Poklis2.   

Abstract

Methamphetamine is a globally abused drug that is metabolized to amphetamine, which also produces abuse-related behavioral effects. However, the contributing role of methamphetamine metabolism to amphetamine in methamphetamine's abuse-related subjective effects is unknown. This preclinical study was designed to determine 1) the relationship between plasma methamphetamine levels and methamphetamine discriminative stimulus effects and 2) the contribution of the methamphetamine metabolite amphetamine in the discriminative stimulus effects of methamphetamine in rhesus monkeys. Adult male rhesus monkeys (n=3) were trained to discriminate 0.18mg/kg intramuscular (+)-methamphetamine from saline in a two-key food-reinforced discrimination procedure. Time course of saline, (+)-methamphetamine (0.032-0.32mg/kg), and (+)-amphetamine (0.032-0.32mg/kg) discriminative stimulus effects were determined. Parallel pharmacokinetic studies were conducted in the same monkeys to determine plasma methamphetamine and amphetamine levels after methamphetamine administration and amphetamine levels after amphetamine administration for correlation with behavior in the discrimination procedure. Both methamphetamine and amphetamine produced full, ≥90%, methamphetamine-like discriminative stimulus effects. Amphetamine displayed a slightly, but significantly, longer duration of action than methamphetamine in the discrimination procedure. Both methamphetamine and amphetamine behavioral effects were related to methamphetamine and amphetamine plasma levels by a clockwise hysteresis loop indicating acute tolerance had developed to the discriminative stimulus effects. Furthermore, amphetamine levels after methamphetamine administration were absent when methamphetamine stimulus effects were greatest and peaked when methamphetamine discriminative stimulus effects returned to saline-like levels. Overall, these results demonstrate the methamphetamine metabolite amphetamine does not contribute to methamphetamine's abuse-related subjective effects.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amphetamine; Drug discrimination; Hysteresis; Methamphetamine; Pharmacokinetics; Rhesus monkey

Mesh:

Substances:

Year:  2015        PMID: 26656213      PMCID: PMC4724286          DOI: 10.1016/j.pbb.2015.12.001

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  46 in total

1.  Acute tolerance to subjective but not cardiovascular effects of d-amphetamine in normal, healthy men.

Authors:  L H Brauer; J Ambre; H De Wit
Journal:  J Clin Psychopharmacol       Date:  1996-02       Impact factor: 3.153

Review 2.  Relationship between the discriminative stimulus properties and subjective effects of drugs.

Authors:  C R Schuster; C E Johanson
Journal:  Psychopharmacol Ser       Date:  1988

3.  Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats.

Authors:  C T Bauer; M L Banks; B E Blough; S S Negus
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

4.  Plasma levels of d-amphetamine in hyperactive children. Serial behavior and motor responses.

Authors:  G L Brown; R D Hunt; M H Ebert; W E Bunney; I J Kopin
Journal:  Psychopharmacology (Berl)       Date:  1979-04-11       Impact factor: 4.530

5.  Methamphetamine disposition in oral fluid, plasma, and urine.

Authors:  Marilyn A Huestis; Edward J Cone
Journal:  Ann N Y Acad Sci       Date:  2007-03-01       Impact factor: 5.691

6.  The rise (and fall?) of drug discrimination research.

Authors:  Lance R McMahon
Journal:  Drug Alcohol Depend       Date:  2015-06-01       Impact factor: 4.492

7.  Retention of sequential drug discriminations under fixed-interval schedules for long time periods without training.

Authors:  Mi Li; Donald E McMillan
Journal:  Eur J Pharmacol       Date:  2003-08-22       Impact factor: 4.432

8.  Methamphetamine and ethanol interactions in humans.

Authors:  J Mendelson; R T Jones; R Upton; P Jacob
Journal:  Clin Pharmacol Ther       Date:  1995-05       Impact factor: 6.875

9.  Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans.

Authors:  Rajkumar J Sevak; William W Stoops; Lon R Hays; Craig R Rush
Journal:  J Pharmacol Exp Ther       Date:  2008-12-22       Impact factor: 4.030

10.  Pharmacokinetic and pharmacodynamic analysis of the actions of D-amphetamine and D-methamphetamine on the dopamine terminal.

Authors:  W P Melega; A E Williams; D A Schmitz; E W DiStefano; A K Cho
Journal:  J Pharmacol Exp Ther       Date:  1995-07       Impact factor: 4.030

View more
  8 in total

1.  Potential Molecular Mechanisms on the Role of the Sigma-1 Receptor in the Action of Cocaine and Methamphetamine.

Authors:  Yuko Yasui; Tsung-Ping Su
Journal:  J Drug Alcohol Res       Date:  2016-02-20

2.  Cocaine-like discriminative stimulus effects of amphetamine, cathinone, methamphetamine, and their 3,4-methylenedioxy analogs in male rhesus monkeys.

Authors:  Douglas A Smith; Bruce E Blough; Matthew L Banks
Journal:  Psychopharmacology (Berl)       Date:  2016-10-05       Impact factor: 4.530

3.  Assessment of tolerance to the effects of methamphetamine on daytime and nighttime activity evaluated with actigraphy in rhesus monkeys.

Authors:  Laís F Berro; Monica L Andersen; Leonard L Howell
Journal:  Psychopharmacology (Berl)       Date:  2017-06-07       Impact factor: 4.530

4.  Role of d-amphetamine and d-methamphetamine as active metabolites of benzphetamine: Evidence from drug discrimination and pharmacokinetic studies in male rhesus monkeys.

Authors:  Matthew L Banks; Rodney W Snyder; Timothy R Fennell; S Stevens Negus
Journal:  Pharmacol Biochem Behav       Date:  2017-03-31       Impact factor: 3.533

5.  Evaluation of the Reinforcing Strength of Phendimetrazine Using a Progressive-Ratio Schedule of Reinforcement in Rhesus Monkeys.

Authors:  Molly Minkiewicz; Paul W Czoty; Bruce E Blough; Michael A Nader
Journal:  J Pharmacol Exp Ther       Date:  2020-04-08       Impact factor: 4.030

6.  Methamphetamine-like discriminative stimulus effects of bupropion and its two hydroxy metabolites in male rhesus monkeys.

Authors:  Matthew L Banks; Douglas A Smith; Bruce E Blough
Journal:  Behav Pharmacol       Date:  2016-04       Impact factor: 2.293

7.  Methamphetamine-Induced Sleep Impairments and Subsequent Slow-Wave and Rapid Eye Movement Sleep Rebound in Male Rhesus Monkeys.

Authors:  Laís F Berro; John S Overton; James K Rowlett
Journal:  Front Neurosci       Date:  2022-04-07       Impact factor: 4.677

8.  The dual orexin receptor antagonist almorexant blocks the sleep-disrupting and daytime stimulant effects of methamphetamine in rhesus monkeys.

Authors:  Lais F Berro; Eliseu da Cruz Moreira-Junior; James K Rowlett
Journal:  Drug Alcohol Depend       Date:  2021-07-28       Impact factor: 4.852

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.